[November 04, 2014]

American Shared Hospital Services Announces Delivery of MEVION S250 Proton Accelerator to UF Health Cancer Center at Orlando Health

AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today the delivery of the superconducting synchrocyclotron proton accelerator-the key element of the MEVION S250™ proton therapy system-to the dedicated proton center now under development at the UF Health Cancer Center at Orlando Health.

AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D., said, "The delivery of the synchrocyclotron for the MEVION S250 is a major step forward in the development of the proton center at the UF Health Cancer Center at Orlando Health. As Central Florida's most advanced cancer center, the UF Health Cancer Center at Orlando Health is the first hospital in the Central Florida region to install a proton therapy system. Construction of the proton center is moving forward, and we expect patient treatments to begin in the first quarter of2016."

About AMS

American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st Century^SM concept. AMS owns a common stock investment in Mevion Medical Systems, Inc., developer of the compact MEVION S250 Proton Therapy System.

Safe Harbor Statement

This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife and radiation therapy businesses, the risks of developing The Operating Room for the 21st Century program, the risks of investing in a development-stage company, Mevion Medical Systems, Inc., and the risks of the timing, financing, and operations of the Company's proton therapy business. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Form 10-K/A for the year ended December 31, 2013, the Form 10-Q for the quarter ended March 31, 2014 and the Form 10-Q and Form 10-Q/A for the quarter ended June 30, 2014, and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 10, 2014.

[ Back To TMCnet.com's Homepage ]